Investing.com - Arcadia Biosciences (NASDAQ: RKDA) reported first quarter EPS of $0.610, $0.78 better than the analyst estimate of $-0.170. Revenue for the quarter came in at $1.39M versus the consensus estimate of $2.3M.
Arcadia Biosciences's stock price closed at $4.560. It is down -11.460% in the last 3 months and down -88.000% in the last 12 months.
Arcadia Biosciences saw positive EPS revisions and negative EPS revisions in the last 90 days. See Arcadia Biosciences's stock price’s past reactions to earnings here.
According to InvestingPro, Arcadia Biosciences's Financial Health score is "weak performance".
Check out Arcadia Biosciences's recent earnings performance, and Arcadia Biosciences's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar